Cited by 1,319Long-Term Effects of COVID-19COVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 Research

Symptom Duration and Risk Factors for Delayed Return to Usual Health Among Outpatients with COVID-19 in a Multistate Health Care Systems Network — United States, March–June 2020

Open access
Tenforde, Mark W., Kim, Sara S., Lindsell, Christopher J., Billig Rose, Erica, Shapiro, Nathan I., Files, D. Clark, Gibbs, Kevin W., Erickson, Heidi L. +34 more·2020·MMWR. Morbidity and Mortality Weekly Report

Abstract

Prolonged symptom duration and disability are common in adults hospitalized with severe coronavirus disease 2019 (COVID-19). Characterizing return to baseline health among outpatients with milder COVID-19 illness is important for understanding the full spectrum of COVID-19-associated illness and tailoring public health messaging, interventions, and policy. During April 15-June 25, 2020, telephone interviews were conducted with a random sample of adults aged ≥18 years who had a first positive reverse transcription-polymerase chain reaction (RT-PCR) test for SARS-CoV-2, the virus that causes COVID-19, at an outpatient visit at one of 14 U.S. academic health care systems in 13 states. Interviews were conducted 14-21 days after the test date. Respondents were asked about demographic characteristics, baseline chronic medical conditions, symptoms present at the time of testing, whether those symptoms had resolved by the interview date, and whether they had returned to their usual state of health at the time of interview. Among 292 respondents, 94% (274) reported experiencing one or more symptoms at the time of testing; 35% of these symptomatic respondents reported not having returned to their usual state of health by the date of the interview (median = 16 days from testing date), including 26% among those aged 18-34 years, 32% among those aged 35-49 years, and 47% among those aged ≥50 years. Among respondents reporting cough, fatigue, or shortness of breath at the time of testing, 43%, 35%, and 29%, respectively, continued to experience these symptoms at the time of the interview. These findings indicate that COVID-19 can result in prolonged illness even among persons with milder outpatient illness, including young adults. Effective public health messaging targeting these groups is warranted. Preventative measures, including social distancing, frequent handwashing, and the consistent and correct use of face coverings in public, should be strongly encouraged to slow the spread of SARS-CoV-2.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.15585/mmwr.mm6930e1

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Pre-existing comorbidities, such as asthma, diabetes, obesity, and immunosuppressive conditions, can also be associated with higher risks of long COVID.

    “Since pre-existing comorbidities, such as asthma, diabetes, obesity, and immunosuppressive conditions, can also be associated with higher risks of long COVID [3,7,8]”

    From Protective effect of COVID-19 vaccination against long COVID syndrome: A systematic review and meta-analysis (2023) · cites this paper as [8]

    The Return to Usual State of Health section associates obesity and having three or more chronic conditions with delayed return to usual health among symptomatic outpatients. Table 1 also shows an association for immunosuppressive conditions, but not for asthma or diabetes. The study assessed recovery 14–21 days after testing, so its findings do not establish risk of longer-term long COVID. (LLM, conf=0.88)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 2

  1. Stubblefield WB, Talbot HK, Feldstein L, et al.; Influenza Vaccine Effectiveness in the Critically Ill (IVY) Investigators. Seroprevalence of SARS-CoV-2 among frontline healthcare personnel during the first month of caring for COVID-19 patients-Nashville, Tennessee. Clin Infect Dis 2020. Epub July 6, 2020. https://doi.org/10.1093/cid/ciaa936 · DOI
  2. Petrie JG, Cheng C, Malosh RE, et al. Illness severity and work productivity loss among working adults with medically attended acute respiratory illnesses: US Influenza Vaccine Effectiveness Network 2012-2013. Clin Infect Dis 2016;62:448-55.

Cited by

Sorted by citations

Authors
Tenforde, M. W., Kim, S. S., Lindsell, C. J., Billig Rose, E., Shapiro, N. I., Files, D. C., Gibbs, K. W., Erickson, H. L., Steingrub, J. S., Smithline, H. A., Gong, M. N., Aboodi, M. S., Exline, M. C., Henning, D. J., Wilson, J. G., Khan, A., Qadir, N., Brown, S. M., Peltan, I. D., Rice, T. W., Hager, D. N., Ginde, A. A., Stubblefield, W. B., Patel, M. M., Self, W. H., Feldstein, L. R., IVY Network Investigators, CDC COVID-19 Response Team, IVY Network Investigators, Hart, K. W., McClellan, R., CDC COVID-19 Response Team, Dorough, L., Dzuris, N., Griggs, E. P., Kassem, A. M., Marcet, P. L., Ogokeh, C. E., Sciarratta, C. N., Siddula, A., Smith, E. R., & Wu, M. J.
Affiliations
  • Centers for Disease Control and Prevention (UG)
  • Beth Israel Deaconess Medical Center (US)
  • Atrium Health Wake Forest Baptist (US)
  • Hennepin County Medical Center (US)
  • Baystate Medical Center (US)
  • Albert Einstein College of Medicine (US)
  • The Ohio State University Wexner Medical Center (US)
  • University of Washington Medical Center (US)
  • Oregon Health & Science University (US)
  • University of California, Los Angeles (US)
  • Intermountain Healthcare (US)
  • Johns Hopkins University (US)
  • Vanderbilt University Medical Center (US)
Corresponding author
Tenforde, Mark W.
Venue
MMWR. Morbidity and Mortality Weekly Report
Published
2020-07-31
Volume
69
Issue
30
Pages
993-998
ISSN
  • 0149-2195 (ISSN-L)
  • 1545-861X
OpenAlex
W3044231852
Cited by
1,319
References
6
Citations by year
2026: 32 · 2025: 74 · 2024: 148 · 2023: 253 · 2022: 335 · 2021: 395 · 2020: 79 · 2018: 3
FWCI
115.07
Type
journal article
Language
en
Open access
Locations
  • MMWR Morbidity and Mortality Weekly Report (publishedVersion)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • eScholarship (California Digital Library) (submittedVersion, cc-by)
Funders
  • U.S. Department of Defense
  • United Therapeutics Corporation
  • Intermountain Research and Medical Foundation
  • Cumberland Pharmaceuticals
  • Regeneron Pharmaceuticals
  • Marcus Foundation
  • University of Oxford
  • National Institutes of Health
  • Centers for Disease Control and Prevention
  • National Institute of General Medical Sciences (K23GM129661)
  • Janssen Pharmaceuticals
  • Actelion Pharmaceuticals
Topics
  • Health Sciences › Medicine › Neurology › Long-Term Effects of COVID-19
  • Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
  • Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
Keywords
COVID-19 pandemic, SARS-CoV-2, prolonged illness, symptom duration, long COVID, fatigue, cough, dyspnea, young adults, chronic disease, risk factors, public health communication, social distancing, face coverings
MeSH terms
COVID-19, Adolescent, Adult, Ambulatory Care, Delivery of Health Care, Female, Humans, Male, Middle Aged, Pneumonia, Viral, Risk Factors, Time Factors, United States, Treatment Outcome, Coronavirus Infections, Recovery of Function, Young Adult, Pandemics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review